Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07677839 · ClinicalTrials.gov registry record · NA
UHFUS Characterization of Normal Lymphatic Anatomy
A NA study, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07677839 is a NA study that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants.
The verdict
NCT07677839, a NA study, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a prospective pilot study of breast cancer patients undergoing axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB). Participants will undergo ultra-high frequency ultrasound (UHFUS) imaging with indocyanine green (ICG) dye to map lymphatic channels between the wrist and elbow to investigate normal lymphatic anatomy in patients with breast cancer.
Interventions
- PROCEDURE Indocyanine green (ICG) solution injection
- DEVICE Ultra-High Frequency Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2036-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07677839
The ClinicalTrials.gov registry entry for NCT07677839 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine green (ICG) solution injection is the first listed.
NCT07677839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07677839 about?
NCT07677839 is a clinical study titled "UHFUS Characterization of Normal Lymphatic Anatomy". This is a prospective pilot study of breast cancer patients undergoing axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB). Participants will undergo ultra-high frequency ultrasound (UHFUS) imaging with indocyanine green (ICG) dye to map lymphatic channels between the wrist an...
What is the current status of trial NCT07677839?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06-17. Estimated completion is 2036-09-01.
What interventions are being tested in trial NCT07677839?
The interventions under investigation include: Indocyanine green (ICG) solution injection (PROCEDURE), Ultra-High Frequency Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT07677839?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.